SFI
IBIO icon

Susquehanna Fundamental Investments’s iBio IBIO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-249
Closed -$192K – 1706
2021
Q1 		$192K Buy
249
+116
+87% +$101K ﹤0.01% 1398
2020
Q4 		$70K Sell
133
-59
-31% -$48.1K ﹤0.01% 1441
2020
Q3 		$195K Buy
+192
New +$278K 0.01% 1203

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Susquehanna Fundamental Investments's IBIO Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of iBio (IBIO) in Q2 2021, closing a stake of 249 shares — an estimated $192K sold.

Susquehanna Fundamental Investments first reported a position in IBIO in Q3 2020 and held it in 3 quarters. The position peaked at $195K in Q3 2020. 83 funds tracked by Wall St. Rank hold IBIO as of Q2 2021.

  • Susquehanna Fundamental Investments reported no remaining iBio position as of Q2 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 249 iBio shares in Q2 2021, an estimated $192K.
  • Susquehanna Fundamental Investments first reported a position in iBio in Q3 2020 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's iBio position peaked at $195K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held iBio as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.